Search research articles
Contact Us
Filters
Showing results (41-50 of 93) with videos related to
Page
of 10
Sort By:
Plos One
|
October 11, 2012
Interleukin 23 promotes hepatocellular carcinoma metastasis via NF-kappa B induced matrix metalloproteinase 9 expression
Jian Li, George Lau, Leilei Chen, et al.
Annals of Saudi Medicine
|
October 27, 2015
Improvement of glucose and lipid metabolism with pegylated interferon-a plus ribavirin therapy in Chinese patients chronically infected with genotype 1b hepatitis C virus
Shao Qing, Dong Ji, Bing Li, et al.
Hepatology International
|
August 12, 2009
Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B
Teerha Piratvisuth, George Lau, You-Chen Chao, et al.
Gastroenterology
|
February 5, 2008
Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approach
Jean-Michel Pawlotsky, Geoffrey Dusheiko, Angelos Hatzakis, et al.
Scientific Reports
|
November 30, 2017
Diverse Changes of Circulating Fibroblast Growth Factor 21 Levels in Hepatitis B Virus-Related Diseases
Liang Wu, Qingchun Pan, Guangyu Wu, et al.
Hepatology International
|
August 1, 2020
Effect of COVID-19 on patients with compensated chronic liver diseases
Dong Ji, Dawei Zhang, Tieniu Yang, et al.
Journal of Hepatology
|
January 8, 2004
EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002 Geneva, Switzerland. Consensus statement (long version)
Roberto de Franchis, Antoine Hadengue, George Lau, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 10, 2020
Prediction for Progression Risk in Patients With COVID-19 Pneumonia: The CALL Score
Dong Ji, Dawei Zhang, Jing Xu, et al.
Hepatology International
|
February 3, 2025
Assessing pricing and affordability of HBV treatment in Asia-Pacific region: a barrier to elimination
Jing Chen, Jidong Jia, Hui Zhuang, et al.
Hepatology International
|
April 20, 2023
Furthering research on MAFLD: the APASL Metabolic fAtty lIver DiseasE coNsortium (MAIDEN)
Jacob George, George Lau, Takumi Kawaguchi, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 93) with videos related to
Sort By:
Page
of 10
Plos One
|
October 11, 2012
Interleukin 23 promotes hepatocellular carcinoma metastasis via NF-kappa B induced matrix metalloproteinase 9 expression
Jian Li, George Lau, Leilei Chen, et al.
Annals of Saudi Medicine
|
October 27, 2015
Improvement of glucose and lipid metabolism with pegylated interferon-a plus ribavirin therapy in Chinese patients chronically infected with genotype 1b hepatitis C virus
Shao Qing, Dong Ji, Bing Li, et al.
Hepatology International
|
August 12, 2009
Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B
Teerha Piratvisuth, George Lau, You-Chen Chao, et al.
Gastroenterology
|
February 5, 2008
Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approach
Jean-Michel Pawlotsky, Geoffrey Dusheiko, Angelos Hatzakis, et al.
Scientific Reports
|
November 30, 2017
Diverse Changes of Circulating Fibroblast Growth Factor 21 Levels in Hepatitis B Virus-Related Diseases
Liang Wu, Qingchun Pan, Guangyu Wu, et al.
Hepatology International
|
August 1, 2020
Effect of COVID-19 on patients with compensated chronic liver diseases
Dong Ji, Dawei Zhang, Tieniu Yang, et al.
Journal of Hepatology
|
January 8, 2004
EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002 Geneva, Switzerland. Consensus statement (long version)
Roberto de Franchis, Antoine Hadengue, George Lau, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 10, 2020
Prediction for Progression Risk in Patients With COVID-19 Pneumonia: The CALL Score
Dong Ji, Dawei Zhang, Jing Xu, et al.
Hepatology International
|
February 3, 2025
Assessing pricing and affordability of HBV treatment in Asia-Pacific region: a barrier to elimination
Jing Chen, Jidong Jia, Hui Zhuang, et al.
Hepatology International
|
April 20, 2023
Furthering research on MAFLD: the APASL Metabolic fAtty lIver DiseasE coNsortium (MAIDEN)
Jacob George, George Lau, Takumi Kawaguchi, et al.
Page
of 10